In a recent article from Medical Device Network they share the exciting news of Affinity Biosensors' recent FDA approval for their LifeScale AST system, which marks a significant leap forward in the realm of infection control and antibiotic stewardship. This innovative technology promises to revolutionise the way healthcare professionals combat antibiotic resistance and optimise patient care.
In the full article they explore the intricacies of Affinity Biosensors' LifeScale AST system and how it is poised to reshape the landscape of infectious disease management and the promising benefits for healthcare facilities and patient outcomes.
Read the full article here: FDA clears Affinity Biosensors’s LifeScale AST diagnostic platform
📰 Source: Medical Device Network
____________________________________________________________________________________________________________________________________________________________________________________________________
Cure Talent is a recruitment agency dedicated to the medical technology industry. Whether you are looking for a new role in the medical device sector or you’re an innovative medical device, digital health, or biotech company looking for staff, get in touch with the team today and explore how Cure Talent can help!